Centuple Global — 360° view

Centuple Global, a company in the Pharmaceuticals industry, reported revenue of ₹279 crore and a net loss of ₹0.48 crore for the March 2026 quarter.

Centuple Global (BSE: CENTUPLE) closed at ₹32.30 on 20 Nov 2026, down 63.4% over the past year. Its market capitalisation is ₹18 crore.

Share price
₹32.30 (20 Nov 2026)
Market cap
₹18 Cr (20 Nov 2026)
Revenue
₹279 Cr (March 2026 quarter)
Net profit
₹-0 Cr (March 2026 quarter)
ROCE
15.0% (FY26)
ROE
12.7% (FY26)
Book value
₹42.5 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹144.40 / ₹28.42 (20 Nov 2026)
1-year return
-63.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: CENTUPLE

Incorporated in 1991, Checkpoint Trends Ltd is in the business of trading and consultancy

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.